Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial

Bulletin Express04-28

Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.

The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.

According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.

The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192500227?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192500227","market":"hk","top_or_hot":-1,"title":"Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial","media":"Bulletin Express","content":"<p>Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.</p>\n<p>The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.</p>\n<p>According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.</p>\n<p>The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech secures RMB4.09 million contract to provide SMO technical services for PIONEER2 clinical trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-28 21:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.</p>\n<p>The contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.</p>\n<p>According to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.</p>\n<p>The Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02158","symbol_name":"医渡科技","start_time":0,"source_url":"","article_id":"1192500227","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192500227","pubTimestamp":1777382665,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02158":"医渡科技"},"translate_title":"医渡科技获得人民币409万元合同，为PIONEER2临床试验提供SMO技术服务","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"Hong Kong–listed Yidu Tech announced that its affiliate, Yidu Cloud (Beijing) Technology Co., Ltd., has won the bid to deliver site management organization (SMO) technical services for the PIONEER2 clinical trial at the First Affiliated Hospital of Guangzhou Medical University.\nThe contract value is approximately RMB4.09 million, underscoring continued commercial traction for Yidu Tech’s data-driven healthcare solutions.\nAccording to the announcement, Yidu Tech leverages artificial intelligence trained on real-world clinical data to streamline decision-making for physicians, pharmaceutical companies, insurers and patients. The PIONEER2 engagement reflects the company’s strategy of embedding proprietary AI capabilities across the healthcare value chain to accelerate precision medicine adoption in China.\nThe Board is chaired by Executive Director Ms. Gong Yingying, with the voluntary announcement dated 28 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192500227","isCrawlerRequest":true}